Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

NCT: NCT05908708 · RECRUITING

NCT IDNCT05908708
StatusRECRUITING
Start Date2023-06-01
Completion2026-07-01

Brief Summary

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Frequently Asked Questions

What is Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes?

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes is a clinical trial registered under NCT05908708. Current status: RECRUITING.

What is the status of NCT05908708?

The current status of NCT05908708 (Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes) is: RECRUITING.

When did Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes start?

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes started on 2023-06-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.